Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Clinical trial NCT03836209 · COMPLETED
Trial details
- NCT number
- NCT03836209
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-06
- Primary completion
- 2023-10-17
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.